Please Wait
Applying Filters...
menu
    • menu
    Antibiotic market to reach US$ 74.07 billion by 2033; FDA approves GSK’s Blujepa for uncomplicated UTIs

    Data Compilation
    #PharmaFlow

    Pipeline Prospector November 2025: Kimberly-Clark to buy Kenvue for US$ 48.7 bn; FDA approves Novartis’ gene therapy

    Stock Recap
    #PipelineProspector

    Menu

    CEFUROXIME AND DEXTROSE IN DUPLEX CONTAINER

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 198Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Log in to download the data

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    29/11/2025 ACS DOBFAR SPA
    Italy
    		 ACS DOBFAR S.P.A. Tribiano IT R1-CEP 1996-007 - Rev 05 Cefuroxime sodium, Sterile 2022-07-25 Valid Chemical 992
    29/11/2025 Fresenius Kabi Anti-Infectives
    Italy
    		 FRESENIUS KABI IPSUM S.R.L. Cassina de’ Pecchi IT R1-CEP 1997-044 - Rev 11 Cefuroxime sodium, Sterile 2021-12-17 Valid Chemical 992